HomeGeneticsGeneMAP2K2 gene
Back to Gene
MAP2K2 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

MAP2K2 gene

The MAP2K2 gene provides instructions for making the MEK2 protein kinase, a critical component of the RAS/MAPK signaling pathway that regulates cell growth, division, and survival.

Normal Function

The MAP2K2 gene provides instructions for making a protein known as MEK2 protein kinase. This protein is part of a signaling pathway called the RAS/MAPK pathway, which transmits chemical signals from outside the cell to the cell's nucleus. RAS/MAPK signaling helps control the growth and division (proliferation) of cells, the process by which cells mature to carry out specific functions (differentiation), cell movement, and the self-destruction of cells (apoptosis).

The MAP2K2 gene is very similar to a gene called MAP2K1, which provides instructions for making a protein known as MEK1 protein kinase. Like MEK2 protein kinase, this protein functions as part of the RAS/MAPK signaling pathway. Together, the MEK1 and MEK2 protein kinases appear to be essential for normal development before birth and for survival after birth.

Health Conditions Related to Genetic Changes

Cardiofaciocutaneous syndrome

At least 13 mutations in the MAP2K2 gene have been identified in people with cardiofaciocutaneous syndrome. Most of these mutations change single protein building blocks (amino acids) in MEK2 protein kinase, although one mutation deletes several amino acids from the protein. These genetic changes abnormally activate MEK2 kinase, which disrupts the tightly regulated RAS/MAPK signaling pathway in cells throughout the body. The altered signaling interferes with the normal development of many organs and tissues, resulting in the characteristic features of cardiofaciocutaneous syndrome.

Other Names for This Gene

  • dual specificity mitogen-activated protein kinase kinase 2
  • ERK activator kinase 2
  • MAP kinase kinase 2
  • MAPK-ERK Kinase 2
  • MAPK/ERK kinase 2
  • MAPKK2
  • MEK2
  • mitogen-activated protein kinase kinase 2, p45
  • MKK2
  • MP2K2_HUMAN
  • PRKMK2

Frequently Asked Questions

CFC syndrome affects multiple body systems. Key features include distinctive facial characteristics (such as a high forehead, widely spaced eyes, and sparse hair), heart defects (like pulmonary stenosis or atrial septal defects), and skin abnormalities (such as dry skin, hyperkeratosis, or eczema). Individuals often experience developmental delays, intellectual disability, and feeding difficulties.
Most cases of cardiofaciocutaneous syndrome are caused by new (de novo) mutations in the MAP2K2 gene (or related genes like BRAF, MAP2K1, or KRAS) that occur spontaneously and are not inherited from a parent. In rare instances, an affected parent can pass on the mutation in an autosomal dominant pattern, meaning only one copy of the altered gene is needed to cause the disorder.
Management of CFC syndrome is multidisciplinary and focuses on addressing specific symptoms. This can include cardiac surgery for heart defects, dermatological care for skin issues, physical and occupational therapy for developmental delays, speech therapy, and nutritional support for feeding difficulties. Regular monitoring by specialists is crucial.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA